logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
25/06/2026
Spot gold fell nearly 1% to $3,962.11 per ounce.
Latest
2 m ago
Hong Kong stock market anomaly | Haiqing Zhiyuan (01392.HK) rose more than 11% during the trading day, indicating that the global multispectral AI market is entering a rapid expansion period. The company takes the lead in high-value scenarios.
2 m ago
From the establishment of Sci-Tech Innovation Index within 50 days, the increase reached 4.00%. Among the component stocks, SinnoCore Corporation rose by 14.95%, Biwin Storage rose by 11.53%, Baolitianheng rose by 11.10%, and HGInfo rose by 8.46%.
3 m ago
Computing power chip concept fluctuates and strengthens, Core Source shares rise more than 10% to hit a record high.
4 m ago
There is no limit on the number of times for transitioning from gasoline to electric vehicles. Beijing will conduct a lottery for allocating 9600 ordinary small passenger car permits.
5 m ago
Hong Kong stocks shock | British Silicon Intelligence (03696.HK) skyrocketed more than 15% in the morning. The first AI-driven candidate drug, Rentosertib, is about to start phase III clinical trials.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.